Product Information
TIMOPTIC 0.5% OCUDOSE DROP is a brand product labeled by Bausch & Lomb Incorporated, priced at $10.3155 per EA under NDC 24208049968. Its NADAC has been published 172 times since May 10, 2023.
FDA first approved this application on Nov 5, 1986. Its Orange Book therapeutic-equivalence code is AT3.
The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6.8 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208049968
Classification
Brand
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
New Drug (NDA)
FDA Application
NDA019463FDA Approved
11/5/1986
TE Code
AT3
On Market Since
2/17/2022
Pharmacological Classes
Price Statistics
The NADAC for TIMOPTIC 0.5% OCUDOSE DROP has been published 172 times since May 10, 2023, and over the history we have for it it has risen 8.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3155 per EA |
|---|---|
| All-time high | $10.3627 (May 14, 2025) |
| All-time low | $9.5494 (May 10, 2023) |
| 52-week high | $10.3155 |
| 52-week low | $10.2449 |
| Median price | $10.2249 |
| Average price | $10.1170 |
| Largest weekly change | +6.0% (Jan 10, 2024) |
| Weeks tracked | 172 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIMOPTIC 0.5% OCUDOSE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TIMOPTIC 0.5% OCUDOSE DROP, manufactured by Bausch & Lomb Incorporated, is $10.3155 per EA (NDC 24208049968), effective Aug 19, 2026.
How has the price of TIMOPTIC 0.5% OCUDOSE DROP changed over time?
Over the history we have for it, the NADAC for TIMOPTIC 0.5% OCUDOSE DROP has risen 8.0%. It has been tracked across 172 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for TIMOPTIC 0.5% OCUDOSE DROP?
Since May 10, 2023, the NADAC for TIMOPTIC 0.5% OCUDOSE DROP has ranged from a low of $9.5494 (May 10, 2023) to a high of $10.3627 (May 14, 2025), with a median of $10.2249 per EA.
Are there cheaper alternatives to TIMOPTIC 0.5% OCUDOSE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL MALEATE 0.5% EYE DROP, is $1.1871 per EA — about 88% below TIMOPTIC 0.5% OCUDOSE DROP.
Who manufactures TIMOPTIC 0.5% OCUDOSE DROP?
TIMOPTIC 0.5% OCUDOSE DROP (NDC 24208049968) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.